Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection

Acta Pharm Sin B. 2020 Jul;10(7):1251-1252. doi: 10.1016/j.apsb.2020.04.013. Epub 2020 Apr 28.

Jingwei Bian^{1

2}, Rongsheng Zhao³, Suodi Zhai³, Zijian Li^{3

2}

¹ Department of Pharmacy, Peking University Third Hospital, Beijing, 100083, China.
² Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital; Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health; Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education; Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, 100083, China.
³ Department of Pharmacy, Peking University Third Hospital, Beijing 100083, China.

No abstract available